Genprex, Inc. financial data

Symbol
GNPX on Nasdaq
Location
1601 Trinity Street, Bldg. B, Suite 3.322, Austin, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % -47.9%
Return On Equity -877 % -114%
Return On Assets -383 % -42.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.27M shares -73.3%
Common Stock, Shares, Outstanding 1M shares -81.7%
Entity Public Float 4.8M USD -90.1%
Common Stock, Value, Issued 1K USD -81.7%
Weighted Average Number of Shares Outstanding, Basic 761K shares +986%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10.1M USD -11.7%
General and Administrative Expense 6.26M USD -45%
Costs and Expenses 16.3M USD -28.4%
Operating Income (Loss) -16.3M USD +28.4%
Net Income (Loss) Attributable to Parent -16.8M USD +26.2%
Earnings Per Share, Basic 57 USD/shares +91.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.1M USD -25.9%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 1.72M USD -10.6%
Property, Plant and Equipment, Net 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Other Assets, Noncurrent 1.85M USD -7.13%
Assets 3.56M USD -8.82%
Liabilities, Current 2.55M USD +13.8%
Liabilities 2.79M USD
Retained Earnings (Accumulated Deficit) -167M USD -11.1%
Stockholders' Equity Attributable to Parent 768K USD -53.9%
Liabilities and Equity 3.56M USD -8.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.16M USD +21.5%
Net Cash Provided by (Used in) Financing Activities 6.03M USD -11.3%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1M shares -81.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.87M USD +26.2%
Deferred Tax Assets, Valuation Allowance 27.6M USD +17.9%
Deferred Tax Assets, Gross 28.2M USD +17.1%
Depreciation 463 USD -95.2%
Deferred Tax Assets, Operating Loss Carryforwards 20.2M USD +19.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 81M USD -49.2%
Additional Paid in Capital 168M USD +10.4%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 928K USD -95.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%